Trial intelligence / Profile preview

T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2

NCT01656200Phase 4Completed

Sponsor
Indian Institute of Science
Start
May 2012
Primary completion
Oct 2013
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of japanese encephalitis vaccine (live attenuated) in Japanese encephalitis (JE), sponsored by Indian Institute of Science. Started May 2012; status: completed.

02

Drugs

japanese encephalitis vaccine (live attenuated)
03

Conditions

Japanese encephalitis (JE)

Beyond the preview

Go deeper on NCT01656200.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01656200.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call